Abstract
Background Medication review with follow-up (MRF) is a professional pharmacy service proven to be cost-effective. Its broader implementation is limited, mainly due to the lack of evidence-based implementation programs that include economic and financial analysis. Objective To analyse the costs and estimate the price of providing and implementing MRF. Setting Community pharmacy in Spain. Method Elderly patients using poly-pharmacy received a community pharmacist-led MRF for 6 months. The cost analysis was based on the time-driven activity based costing model and included the provider costs, initial investment costs and maintenance expenses. The service price was estimated using the labour costs, costs associated with service provision, potential number of patients receiving the service and mark-up. Main outcome measures Costs and potential price of MRF. Results A mean time of 404.4 (SD 232.2) was spent on service provision and was extrapolated to annual costs. Service provider cost per patient ranged from €196 (SD 90.5) to €310 (SD 164.4). The mean initial investment per pharmacy was €4594 and the mean annual maintenance costs €3,068. Largest items contributing to cost were initial staff training, continuing education and renting of the patient counselling area. The potential service price ranged from €237 to €628 per patient a year. Conclusion Time spent by the service provider accounted for 75–95% of the final cost, followed by initial investment costs and maintenance costs. Remuneration for professional pharmacy services provision must cover service costs and appropriate profit, allowing for their long-term sustainability.
Similar content being viewed by others
References
World Health Organization. The world health report: primary health care now more than ever. Switzerland: World Health Organization; 2008. [Cited 21 Dec 2015]. (ISBN: 9789241563734). http://www.who.int/whr/2008/whr08_en.pdf.
Al Hamid A, Ghaleb M, Aljadhey H, Aslanpour Z. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol. 2014;78(2):202–17.
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.
Hovstadius B, Petersson G. The impact of increasing polypharmacy on prescribed drug expenditure—a register-based study in Sweden 2005–2009. Health Policy. 2013;109(2):166–74.
Rotta I, Salgado TM, Silva ML, Correr CJ, Fernandez-Llimos F. Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000–2010). Int J Clin Pharm. 2015;37(5):687–97.
Garcia-Cardenas V, Armour C, Benrimoj SI, Martinez-Martinez F, Rotta I, Fernandez-Llimos F. Pharmacists’ interventions on clinical asthma outcomes: a systematic review. Eur Respir J. 2016;47(4):1134–43.
Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569–82.
Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770–81.
Ocampo CC, Garcia-Cardenas V, Martinez-Martinez F, Benrimoj SI, Amariles P, Gastelurrutia MA. Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes. Int J Clin Pharm. 2015;37(5):931–40.
Jodar-Sanchez F, Malet-Larrea A, Martin JJ, Garcia-Mochon L, Lopez Del Amo MP, Martinez-Martinez F, et al. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program. Pharmacoeconomics. 2015;33(6):599–610.
Benrimoj SI, Feletto E, Gastelurrutia MA, Martinez-Martinez F, Faus MJ. A holistic and integrated approach to implementing cognitive pharmaceutical services. Ars Pharm. 2010;51:69–87.
Accounting Management Commission. Cost Strategic Management. Document 23. 1st ed. Madrid: Spanish Association of Accounting and Business Management; 2001. p. 120.
Kaplan R, Robert S. Research opportunities in management accounting. J Manag Acc Res. 1993;5:1–14.
Rupp M, Warholak T. Evaluation of e-prescribing in chain community pharmacy: best-practice recommendations. J Am Pharm Assoc. 2008;48(3):364–70.
Doucette W, McDonough R, Mormann M, Vaschevici R, Urmie J, Patterson B. Three-year financial analysis of pharmacy services at an independent community pharmacy. J Am Pharm Assoc. 2012;52(2):181–7.
Liu Y, Nevins J, Carruthers K, Doucette W, McDonough R, Pan X. Osteoporosis risk screening for women in a community pharmacy. J Am Pharm Assoc. 2007;47(4):521–6.
McDonough RP, Harthan AA, McLeese KE, Doucette WR. Retrospective financial analysis of medication therapy management services from the pharmacy’s perspective. J Am Pharm Assoc. 2010;50(1):62–6.
Anderson S, Schumock G. Evaluation and justification of clinical pharmacy services. Expert Rev Pharmacoecon Outcomes Res. 2009;9(6):539–45.
Plumridge R, Wojnar-Horton R. A review of the pharmacoeconomics of pharmaceutical care. Pharmacoeconomics. 1998;14(2):175–89.
Martinez-Martinez F, García-Cardenas V, Sanz-Benito L, Varas R, Gastelurrutia M, Sabater-Hernandez D, et al. [conSIGUE Program. Evaluation of the clinical, economic and humanistic impact of medication review with follow-up in aged patients using polypharmacy]. Vitae. 2013;20(Suppl1):S15–S8.
Martinez-Martinez F, Farragher T, Faus M, Garcia-Cardenas V, Gastelurrutia M, Jodar F. Clinical, economic and humanistic outcomes of medication review with follow-up in aged polypharmacy patients in the Spanish community pharmacy. Madrid: General Council of Spanish Pharmacists; 2014. [Cited 19 Dec 2015]. (ISBN: 9788487276835). http://www.pharmaceutical-care.org/archivos/992/V2-Resultados-Definitivos-Programa-Consigue-Impacto-2011-2014.pdf.
Pharmaceutical Care Forum. Expert Panel. Consensus Document. Madrid: General Council of Spanish Pharmacists; 2010. [Cited 19 Feb 2015]. (ISBN: 9788469112434). http://www.portalfarma.com/inicio/atencionfarmaceutica/forodeattfarma/Documents/DocumentodeConsensodeForo2008.pdf.
Everaert P, Bruggerman W. Time-driven activity-based costing: exploring the underlying model. Cost Manag. 2007;21(2):16–20.
Kaplan RS, Anderson SR. Time-driven activity based-costing. A simpler and more powerful path to higher profits. 5th ed. Boston: Harvard Business Press; 2007. p. 265. (ISBN: 1422101711).
Noain M, Gastelurrutia M, Martínez-Martínez F, Benrimoj S. Costs’ identification of the sustainable provision of the medication management service. Pharm Care Esp. 2014;16(5):180–92.
Spanish Goverment. [Resolution of the 7th January 2011 by the General Labour Office, registering and publishing the XXIII colective agreement for community pharmacies]; 2011. [Cited 12 Sept 2015]. http://www.boe.es/boe/dias/2011/01/24/pdfs/BOE-S-2011-20.pdf.
Asesoria Especializada en Farmacias. [Annual community pharmacy report]. Aspime; 2011. [Cited 20 Sept 2015]. http://www.aspime.es/asesoramiento/InformeAnualOficinasdeFarmacia2011ASPIMEVersionweb.pdf.
Spanish Goverment. [Law 26/2009, 23rd December, of General National State Budget for 2010. BOE No. 309, 24th December 2009]; 2009. [Cited 2 Nov 2015]. http://www.boe.es/boe/dias/2009/12/24/pdfs/BOE-A-2009-20765.pdf.
Ministry of Health, Social Services and Equality; 2012. [Cited 16 Dec 2015]. http://www.seg-social.es/Internet_6/Trabajadores/Afiliacion/Afiliaciondetrabaja7332/index.htm.
National Statistics Institute. [Working time survey]; 2000. [Cited 2 Nov 2015]. http://www.ine.es/dynt3/inebase/index.htm?type=pcaxis&path=/t22/p186/a2000&file=pcaxis&L=0.
Financial Accounting Standards Board. [Statement of Financial Accounting Concepts No. 6. Elements of Financial Statements]; 1985. [Cited 1 July 2015]. http://www.fasb.org/jsp/FASB/Document_C/DocumentPage?cid=1218220132802&acceptedDisclaimer=true.
Fontanesi J, Jue-Leong S. Logistical and fiscal sustainability of a school-based, pharmacist-administered influenza vaccination program. J Am Pharm Assoc. 2012;52(5):e74-e79.
Regulation (EC) No 1606/2002 of the European Parliament and of the Council of 19 July 2002 on the application of international accounting standards. 2008. [Cited 22 Jan 2015]. http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=URISERV:l26040.
Spanish Goverment. [Law 1515/2007, 16th November, aproving the general accounting plan for small and medium business and specific accounting criteria for microbusiness. BOE No. 279. 21st November 2007]; 2007. [Cited 8 Sept 2015]. http://www.boe.es/boe/dias/2007/11/21/pdfs/A47560-47566.pdf.
Huttin C. A critical review of the remuneration systems for pharmacists. Health Policy. 1996;36:53–68.
Vogler S, Zimmermann N, Leopold C, de Joncheere K. Pharmaceutical policies in European countries in response to the global financial crisis. South Med Rev. 2011;4(2):69–79.
Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: a systematic review of remunerated pharmacy clinical care services. Can Pharm J. 2014;147(4):209–32.
Gastelurrutia MA, Benrimoj SI, Castrillon CC, Casado de Amezua MJ, Fernandez-Llimos F, Faus MJ. Facilitators for practice change in Spanish community pharmacy. Pharm World Sci. 2009;31(1):32–9.
Gil M, Benrimoj S, Martínez-Martínez F, Cardero M, Gastelurrutia M. Priorization of facilitators for the implementation of medication review with follow-up service in Spanish community pharmacies through exploratory factor analysis. Aten Primaria. 2013;45(7):368–75.
Garcia-Cardenas V, Benrimoj SI, Ocampo CC, Goyenechea E, Martinez-Martinez F, Gastelurrutia MA. Evaluation of the implementation process and outcomes of a professional pharmacy service in a community pharmacy setting. A case report. Res Soc Adm Pharm. 2016. doi:10.1016/j.sapharm.2016.05.048.
Noain M, Gastelurrutia M, Martínez-Martínez F, Benrimoj S. Potential remuneration models for medication review with follow-up service in community pharmacy. Pharm Care Esp. 2015;17(4):423–41.
Mossialos E, Courtin E, Naci H, Benrimoj S, Bouvy M, Farris K, et al. From, “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy. 2015;119(15):628–39.
Rosenthal M, Grindrod K, Lynd L, Marra C, Bougher D, Wilgosh C, et al. Pharmacists´perspectives on providing chronic disease management services in the community—part II: development and implementation of services. Can Pharm J. 2009;142(6):284–8.
Brummel A, Lustig A, Westrich K, Evans M, Plank G, Penso J, et al. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management. JMCP. 2014;20(12):1152–8.
Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: a systematic review of remunerated pharmacy clinical care services. Can Pharm J (Ott). 2014;147(4):209–32.
Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42(6):861–8.
Funding
This study was funded by Cinfa Laboratories.
Conflicts of interest
All the authors have declared they have no conflict of interest.
Availability of data and materials
The data that support the findings of this study are available on request from the corresponding author (VGC). The data are not publicly available due to relevant data protection laws.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Noain, A., Garcia-Cardenas, V., Gastelurrutia, M.A. et al. Cost analysis for the implementation of a medication review with follow-up service in Spain. Int J Clin Pharm 39, 750–758 (2017). https://doi.org/10.1007/s11096-017-0454-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-017-0454-2